HomeAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$1.21
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$1.21
Sarado: Peb 2, 5:40:25 PM GMT-5 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$1.15
Sakop ng araw
$1.10 - $1.23
Sakop ng taon
$1.07 - $20.33
Market cap
3.46M USD
Average na Volume
150.17K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 26.00K | -25.71% |
Gastos sa pagpapatakbo | 2.40M | -46.74% |
Net na kita | -3.28M | 11.24% |
Net profit margin | -12.63K | -19.48% |
Kita sa bawat share | -1.57 | 77.21% |
EBITDA | -2.39M | 45.93% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.41M | -66.55% |
Kabuuang asset | 5.49M | -59.57% |
Kabuuang sagutin | 11.57M | 8.38% |
Kabuuang equity | -6.08M | — |
Natitirang share | 2.86M | — |
Presyo para makapag-book | -0.52 | — |
Return on assets | -127.14% | — |
Return on capital | 163.57% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.28M | 11.24% |
Cash mula sa mga operasyon | -5.08M | -63.31% |
Cash mula sa pag-invest | 296.00K | -11.38% |
Cash mula sa financing | 6.65M | 4,756.93% |
Net change in cash | 1.87M | 170.90% |
Malayang cash flow | -7.41M | -315.84% |
Tungkol
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Itinatag
1966
Headquarters
Website
Mga Empleyado
22
